ARF Bio Yenilenebilir Enerji Üretim A.S. (IST:ARFYE)

IST:ARFYE Income Statement

Financials in millions TRY. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	91.49	163.3	-
Revenue Growth (YoY)	-43.97%	-	-
Cost of Revenue	72.14	28.96	-
Gross Profit	19.35	134.34	-
Selling, General & Admin	4.8	2.04	0.24
Other Operating Expenses	0.44	0.53	0.56
Operating Expenses	5.24	2.57	0.8
Operating Income	14.11	131.77	-0.8
Interest Expense	-10.86	-4.87	-
Interest & Investment Income	7.89	2.78	1.96
Currency Exchange Gain (Loss)	-0.11	0.6	-0.2
EBT Excluding Unusual Items	11.02	130.28	0.96
Gain (Loss) on Sale of Investments	-	-1.31	-
Pretax Income	11.02	128.97	0.96
Income Tax Expense	6.01	27.15	0.54
Net Income	5.01	101.82	0.42
Net Income to Common	5.01	101.82	0.42
Net Income Growth	-95.08%	24098.24%	-
Shares Outstanding (Basic)	105	41	2
Shares Outstanding (Diluted)	105	41	2
Shares Change (YoY)	155.44%	1959.99%	-
EPS (Basic)	0.05	2.47	0.21
EPS (Diluted)	0.05	2.47	0.21
EPS Growth	-98.08%	1074.68%	-
Free Cash Flow	-25.04	-208.43	-1.86
Free Cash Flow Per Share	-0.24	-5.06	-0.93
Gross Margin	21.15%	82.27%	-
Operating Margin	15.42%	80.69%	-
Profit Margin	5.47%	62.35%	-
Free Cash Flow Margin	-27.37%	-127.64%	-
EBITDA	20.68	135.25	-0.74
EBITDA Margin	22.60%	82.82%	-
D&A For EBITDA	6.57	3.48	0.06
EBIT	14.11	131.77	-0.8
EBIT Margin	15.42%	80.69%	-
Effective Tax Rate	54.57%	21.05%	56.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.